Martin Haluzík
Martin Haluzík
A worldwide increase in the prevalence of obesity and type 2 diabetes mellitus along with accompanying chronic, in particular cardiovascular, complications represents one of the leading challenges of current medicine. Despite major advances...
Jana Bělobrádková
Jana Bělobrádková
There is a groving number of women with pregestational diabetes mellitus. Additionaly, nowadays therapy of diabetes mellitus type I allows gravidity even in patients in whom diabetes manifested itself during their early childhood. Presence ...
[Education of a patient with diabetes - an integral part of complex therapy] [0.03%]
糖尿病人的教育——综合治疗的重要部分
Alena Adamíková
Alena Adamíková
Determination of the diagnosis of diabetes mellitus means a radical life change for a patient. Education of a patient with diabetes means the provision of essential information and practical guidance for linkage of the disease with the life...
[Frequency and timing of meals and changes in body mass index: Analysis of the data from the Adventist Health Study-2] [0.03%]
[餐食频率和体重指数变化的关系——来自前瞻性 Adventist 健康研究-II 数据的分析]
Hana Kahleová,Jan Irene Lloren,Andrew Mashchak et al.
Hana Kahleová et al.
Goal: Our study focuses on examining the relationship between the frequency and timing of meals and changes in BMI in the Adventist Health Study-2 (AHS-2) which represents a relatively healthy population in North America....
[Metabolic syndrome in patients with diabetes mellitus type 1, prevalence, impact on morbidity and mortality] [0.03%]
1型糖尿病患者的代谢综合征：患病率及其对病死率和病残率的影响
Jitka Brožová,Daniela Čechurová,Silvie Lacigová
Jitka Brožová
Aim of this retrospective observational study was to determine the prevalence of metabolic syndrome (MS) in patients with diabetes mellitus type 1 (DM1Z) at baseline (in 2003) and find the parameters that determine the difference between gr...
Observational Study
Vnitrni lekarstvi. 2016 Fall;62(11 Suppl 4):S8-14. DOI: 2016
[Diabetic foot syndrome from the perspective of internist educated in podiatry] [0.03%]
内科医师的足病观念在糖尿病性足病变中的作用
Alexandra Jirkovská
Alexandra Jirkovská
Podiatry is the science dealing with the diagnostics and treatment of the foot and ankle and associated tissues and structures by all appropriate methods and also with the local manifestation of the overall processes in this area. Diabetic ...
[Arterin - a nutritional supplement in the treatment of dyslipidemia: results of a short-term clinical follow-up study] [0.03%]
arterin在治疗脂代谢紊乱中的作用：短期临床随访研究结果
Miroslav Souček
Miroslav Souček
Elevated LDL-cholesterol levels are among the main risk factors for ischemic heart disease. It can be influenced by pharmacotherapy, but also by changes in eating and life habits. The most recent recommendations on the treatment of dyslipid...
Igor Šturdík,Martin Kužma,Zuzana Kužmová et al.
Igor Šturdík et al.
Hemosuccus pancreaticus is a rare cause of upper digestive tract bleeding, it is hemorrhage to the pancreatic duct. A case report is about 56-years old man who was repeatedly hospitalized and suffered from melena and enterorrhagia during 3 ...
Case Reports
Vnitrni lekarstvi. 2016 Fall;62(10):833-836. DOI: 2016
[Evaluation of five years of treatment of Erdheim-Chester disease with anakinra: case report and overview of literature] [0.03%]
[关于Erdheim-Chester病使用anakinra治疗的五年评估：病例报告和文献综述]
Zdeněk Adam,Hana Petrášová,Zdeněk Řehák et al.
Zdeněk Adam et al.
Erdheim-Chester disease is a histiocytic neoplasm of diseases from the group of non-Langerhans-cell histiocytoses, formed by infiltrates of foamy histiocytes. These pathological histiocytes produce pro-inflammatory cytokines. Therefore Erdh...
[Rivaroxaban use in prevention of stroke in patients with non-valvular atrial fibrillation in clinical practice, results of observational studies and our experience] [0.03%]
[阿哌沙班预防非瓣膜性房颤患者卒中的临床应用、观察性研究结果及体会]
Filip Málek
Filip Málek
Rivaroxaban is direct oral factor Xa inhibitor indicated for tromboembolic event rate reduction in patients with non-valvular atrial fibrillation. Knowledge of rivaroxaban efficacy and safety comes from a phase III randomized clinical trial...